REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/23/2026
Back to search
Official data from USPTO
POTELLIGENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
POTELLIGENT
ST13
US500000078219523Class
1, 5, 40
Filing
78219523
Registration
3200292
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
01/24/2026
Trademark type
Word
Nice classes
1, 5, 40
Filing date
02/27/2003
Registration date
01/23/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2017
Last transaction
01/24/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
1
Owner type
03
Owner location
TOKYO, JP
Examiner
GRIFFIN, JAMES
Law office
L30
Current location
TMEG LAW OFFICE 103
Holders and representatives
Holders
KYOWA KIRIN CO., LTD.
KYOWA HAKKO KIRIN CO., LTD.
Kyowa Hakko Kogyo Co., Ltd.
Representatives
Kaushal R. Odedra ODEDRA LAW OFFICE, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cells that manufacture antibodiesfragments of antibodies or derivatives of antibodies for medical research; transfected cells that manufacture antibodiesfragments of antibodies or derivatives of antibodies for medical research
Class 5
Cells that manufacture antibodiesfragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodiesfragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticalscentral nervous system depressantspreparations for ophthalmic useanti-histaminicscardiotonicsarrhythmia treating agentsdiureticshypotensorsprophylactic for the treatment of asthmaantitussives and expectorantsstomachics and digestivesantacidshormonespituitary hormones for the treatment of infertilitythyroid hormones for the treatment of hyperthyroidismanabolic hormones for the treatment of aplastic anemia and osteoporosiscorticosteroids for treatment of hypopituitarismcongenital adrenal hyperplasiarheumatoid arthritisrheumatic fevercrohn's diseasechronic active hepatitisestrogen and progesterone used as combined oral contraceptivesurinary antisepticsanalgesicsanti-itching agentscataplasms for the treatment of bruiseslumbago and stiff shoulderpharmaceutical preparations used to treat hair disordersanti-coagulantsenzyme preparations for control of malabsorption and diarrheaanti-cancer preparationsanti-sarcoma preparationsantibiotics and their preparations for the treatment of infectious diseasesantituberculotic agentsinfluenza vaccinesdiphtheria vaccinestetanus vaccinesgas gangrene vaccinesJapanese encephalitis vaccinesin vitro tetrodotoxines for medical useantiprotozoals for the treatment of trichomoniasis and dermatophytosisanthelmintics for the treatment of threadworm and toxoplasmaosisnaturally occurring drugs for treating peptic ulcerscharred drugs for treating peptic ulcersmoxa for treating peptic ulcersveterinary drugs for the treatment of distemper in dogsdistomatosis in dogscoccidium in chickensdysentery in pigsdrugs for arteriosclerosisoncostatic drugs for the treatment for cancermultienzyme digestants for in vivo useantifungal antibiotics for treating trichomoniasis and dermatophytosisantiparkinsonism drugsminor tranquilizersantianxiety agentsmedicinal preparations for the treatment of the central nervous systemthe respiratory tract and the cardiovascular systemanti-bacterial preparationsmucolytic preparationsmedicinal preparations for the treatment of peptic ulcersanti-inflammatory preparationsanalgesic preparationscephalosporincocarboxylase preparationsglutathione preparationspreparations for improving the metabolism and the peripheral circulationplasma substitutes and extracorporeal circulation flow improvement preparationsdiuretic and anti-hypertensive preparationspharmaceutical preparations for the treatment of insomnia and other sleep related diseases
Class 40
Contract manufacturing service in the field of cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodiesfragments of antibodiesderivatives of antibodies; contract extractingrefiningsynthesizingmanufacturing and preparing pharmaceuticalsagricultural chemicalschemicals
Publications
History of USPTO decisions and trademark events.
55 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/04/2019
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/17/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/17/2017
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
03/17/2017
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
03/17/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/17/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
01/20/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
07/09/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/09/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/09/2013
E815
TEAS SECTION 8 & 15 RECEIVED
06/23/2013
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
11/19/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2007
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
12/05/2006
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/30/2006
FAXX
FAX RECEIVED
11/30/2006
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
10/17/2006
PUBO
PUBLISHED FOR OPPOSITION
07/25/2006
NPUB
NOTICE OF PUBLICATION
07/05/2006
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/01/2006
ALIE
ASSIGNED TO LIE
05/26/2006
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/24/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/17/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/17/2006
CNCF
CONTINUATION OF FINAL REFUSAL MAILED
04/28/2006
CNCF
ACTION CONTINUING A FINAL - COMPLETED
04/27/2006
CNEA
EXAMINERS AMENDMENT MAILED
04/27/2006
XAEC
EXAMINER'S AMENDMENT ENTERED
04/27/2006
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/27/2006
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/21/2006
CNFR
FINAL REFUSAL MAILED
03/06/2006
CNFR
FINAL REFUSAL WRITTEN
03/03/2006
ACEC
AMENDMENT FROM APPLICANT ENTERED
02/09/2006
PAPER RECEIVED
02/07/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/03/2006
PAPER RECEIVED
02/03/2006
CRML
CORRESPONDENCE MAILED
10/18/2005
CNRT
NON-FINAL ACTION WRITTEN
10/18/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
09/26/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/19/2005
PAPER RECEIVED
09/19/2005
CNSL
LETTER OF SUSPENSION MAILED
05/13/2005
CNSL
SUSPENSION LETTER WRITTEN
05/12/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/10/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/02/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/02/2005
CNSI
INQUIRY AS TO SUSPENSION MAILED
11/22/2004
CNSI
SUSPENSION INQUIRY WRITTEN
11/19/2004
CNSL
LETTER OF SUSPENSION MAILED
03/26/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2004
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2004
CNRT
NON-FINAL ACTION MAILED
08/19/2003
DOCK
ASSIGNED TO EXAMINER
08/14/2003
Continuous trademark protection
Get notified about every new filing that threatens POTELLIGENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.